Predicting absolute risks for oesophageal adenocarcinoma (#52)

1:30 PM

Aaron P Thrift

SOX9 drives columnar differentiation in squamous oesophageal epithelial cells – a putative mechanism in the development of Barrett’s oesophagus (#53)

1:40 PM

Nicholas J Clemons

Evaluation of plasma exosomal microRNA-21 as a circulating biomarker in oesophageal adenocarcinoma (#54)

1:50 PM

Tingting Wang

Serum glycoprotein biomarker discovery for Barrett’s oesophagus and oesophageal adenocarcinoma – towards the development of diagnostic blood tests (#55)

2:00 PM

Michelle M Hill

VICTORIAN BARRETT’S EXPERIENCE: OUTCOMES OF PATIENTS UNDERGOING COMBINATION ENDOSCOPIC THERAPY FOR DYSPLASTIC BARRETT’S OESOPHAGUS (#56)

2:10 PM

Andrew Taylor

HER2 STATUS IN BARRETT’S OESOPHAGUS AND OESOPHAGEAL CANCER: A META ANALYSIS (#57)

2:20 PM

Ashwini Gowryshankar

ANALYSIS OF THE EXPRESSION OF ESTROGEN RECEPTORS ALPHA AND BETA IN OESOPHAGEAL ADENOCARCINOMA (#58)

2:30 PM

Olga A Sukocheva

Variation in the surgical management of oesophageal carcinoma in NSW, 2001-2007 (#59)

2:40 PM

Jason P. Bentley

MEAT CONSUMPTION AND RISK OF DEVELOPING OESOPHAGEAL CANCER: A META-ANALYSIS (#60)

2:50 PM

Guy D. Eslick